ever, TG and VLDL cholesterol values of controls and cirrhosis groups were similar (p 1 0.05). We did not register any differences between the two cirrhosis groups (p 1 0.05). Conclusion: Our data showed that both HCV and HBV cirrhosis severely impaired liver lipid metabolism. Late stages of the disease resulted in a pseudonormalization of VLDL cholesterol and TG values.
Introduction
The liver plays a central role in lipid metabolism, as several pathways are, at least in part, dependent to this site [1] . Major metabolic processes take place at this level, involving the production, transportation and storage of apoproteins and lipoproteins, as well as catabolism of various lipids and excretion of cholesterol and phospholipids. An alteration in liver functions resulting from cellular injury leads to changes in the serum concentration of cholesterol and lipoproteins [2] [3] [4] [5] .
Infection with hepatitis C (HCV) or B (HBV) viruses leads to hepatic damage, which in turn relates to changes in alterations of the lipid metabolism [6] [7] [8] [9] [10] . Different mechanisms are involved, dependent on the stage of the liver disease and the metabolic state [11] [12] [13] . Low levels of plasma cholesterol and lipoproteins, as well as lower triglyceride (TG) values are usual in chronic liver diseases. However, the number of studies which included patients
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Subjects and Methods
This study was conducted in the 1st Medical Clinic of the Emergency County Hospital, Craiova, Romania, from January 2006 to January 2011. A total of 90 patients were selected, as follows: 30 with hepatic cirrhosis of HCV origin, 30 with hepatic cirrhosis of HBV origin and 30 patients with no known liver diseases. The diagnosis of cirrhosis was established on anamnestic, clinical and laboratory findings, imaging (ultrasonography and upper endoscopy) and liver biopsy. No patients underwent antiviral therapy. All the patients live in the same geographic area, with similar body mass indices and similar dietary habits. All the patients were in advanced stages of cirrhosis (Child B and C). Exclusion criteria were primary disproteinemia or disproteinemia associated with other pathologies (diabetes mellitus, nephrotic syndrome, hypothyroidism or other metabolic syndromes); body mass index 1 30 and alcohol consumption as well as prior treatments with estrogens, ␤ -blockers, diuretics or cortisol medication.
Serum lipids, total cholesterol and cholesteryl ester, HDL cholesterol, LDL cholesterol, VLDL cholesterol and TG values were measured using colorimetric enzyme methods (Kobas 6000 analyzer; Roche Diagnostics, USA).
Statistical analysis of these parameters was performed using the ANOVA test followed by Tukey multiple comparison tests; Bartlett's statistic was used to test for equal variances; p ! 0.05 was considered statistically significant. All statistical calculations were performed using the Graph Pad Prism software (InStat, USA).
Results
Patients were similar in terms of gender and age ( table 1 ). All three groups were similar in terms of age distribution (median ages 50.87, 49.83 and 47.93 years, respectively), ranging between 30 and 70 years. The male population was predominant in our cohort, with a total of 57 men (63.3%) and a similar gender distribution in all three groups. Bartlett's statistic showed normal distribution of the variances in all samples.
The comparisons of serum values for lipids, total cholesterol, cholesteryl esters, HDL, LDL and VLDL cholesterol and TG for all three groups are given in table 2 . The differences between the controls and both cirrhotic groups for serum lipids (p ! 0.001), total cholesterol (p ! 0.001), cholesteryl esters (p ! 0.001), HDL (p ! 0.05) and LDL cholesterol (p ! 0.001) were statistically significant. However, there was no statistically significant difference between TG and VLDL cholesterol values of controls and any of the two cirrhosis groups (p 1 0.05). Also, cirrhotic patients had similar values for all serum parameters, irrespective of the viral etiology (p 1 0.05).
Discussion
Our results indicated that serum levels of lipid, total cholesterol and cholesteryl ester, as well as HDL and LDL cholesterol (but not VLDL cholesterol) were lower in pa- tients with advanced stages of liver disease, irrespective of their viral etiology. No changes were observed in TG levels of the three groups. No differences were observed between the patients with HBV and HCV either, thereby proving that the advanced stages of liver disease and subsequent organ failure were similar, irrespective of the viral etiology.
As we had previously shown [9] , cholesterol and TG levels were influenced by the etiology and severity of chronic viral hepatitis, being in direct relation with the histological activity score and steatosis. The present study has taken the paradigm further, proving that the etiological differences that existed with the onset of cirrhosis were leveled at the advanced stage due to the inherent hepatocyte damage.
Previous studies [2, 3, 5, 6, 14] had established a connection between liver damage due to viral infection and a decline in cholesterol and apolipoprotein metabolism. This relationship was further demonstrated by recent basic and clinical research aimed at uncovering the mechanisms behind these alterations [7, 10, 13, 15] . While the interference from viral infection is clearly established, only a limited number of studies further details how liver cirrhosis, especially in advanced stages, alters lipid metabolism.
Our findings confirmed previous studies [7, 8, 10, 16, 17] that revealed an alteration of lipid metabolism in advanced stages of viral liver cirrhosis principally because hepatocyte alteration was already profound. Patients were preselected in advanced disease stages, thus hepatocyte alteration was already profound.
Several studies found lower TG levels in HCV-or HBV-infected patients without cirrhosis. In our study, however, TG levels were similar in all three groups. This is probably due to the fact that in late stages of hepatic disease, the activity of TG lipase (the enzyme responsible for hydrolyzing ester linkages of TGs) is severely impaired [6] .
